'Loss of support' for disabled university students
Disabled students at the University of Derby are calling for more specialist support to be available during their studies, after the university made changes to its disability support.
A group called the Independent Disabled Students Network (IDSN), which was formed to challenge decisions made by the university, said there had been a "significant reduction in disability support across the university".
Sonja Brown, 58, a disabled student, told the BBC: "It's stressful and frustrating that we weren't considered. I feel like I'm a second class citizen and that they couldn't speak to me and get my point of view."
The university denied removing any support for students with disabilities.
The IDSN group claim the university has scrapped deadline extensions, extra time in examinations and single-diagnosis support plans for students.
James Earnes, 28, a student and founder of the group said: "To date, the university has not issued a formal policy or public statement clarifying the current position on support entitlements.
"Multiple students have raised complaints, and we have started to rely on Freedom of Information requests to access basic information about policies that directly affect our ability to study."
Sonja, who is studying a masters degree in international tourism and hospitality, says she lost support that was previously available to her during her undergraduate studies.
"I was here from 2020 to 2023. I had a Disabled Students' Allowance (DSA) in place and got support and extensions.
"I came back in September 2024 to find I still have my support plan but not my extensions, because they want to make it a level playing field.
"Not only do I have a hidden disability, I've got a physical disability.
"It just means more stress for us. If I had known about the changes at the open day, I would have considered going to another university."
Rosie Henrick, 25, a disabled psychology student who is autistic, has ADHD and general anxiety disorder, says the changes are taking a toll on their health.
They said: "It has a psychical and mental negative impact. I've been getting a lot more high heart rate notifications. I'm very stressed out.
"I don't think I can be there next year if they don't change stuff.
"I get good grades but I also don't want my health to decline. It definitely is, and I've been noticing it."
George Butler, 19, a disabled civil engineering student who also acts as a student representative said: "It's a lot more mental stress for disabled students.
"To expect more and more of a person that you're taking more and more away from, means they'll be able to work less."
The group is also challenging the university over its decision to introduce fares to the Unibus, a bus service that is free for students and staff until 31 July 2025.
Darren Cassidy, 32, a disabled health and social care student, said: "We've had some reviews with the walking routes that they've suggested for people.
"It's not appealing to a disabled student because there's not very good walkways, hardly any lighting and no dropped kerbs.
"It's really damaging for a disabled student. Not only do they see physical support being removed from their educational system, but they're also seeing actual barriers to getting to the university as well.
"A lot of disabled students have extra things they have to pay for such as care, extra food, medications or whatever else may be affecting them personally.
"To have an extra charge on top, I find it really difficult for them. I've heard people say they wouldn't come in as much, and that to me doesn't seem very welcoming to disabled students."
A spokesperson for the university said: "The university has not removed any support for its students with disabilities.
"Historically we applied a blanket approach whereas now we are improving our support and providing a bespoke service which aims to ensure each student has what they need to thrive.
"The option of providing extensions to deadlines or extra time in exams, remains for those students with a disability for whom this is an appropriate support mechanism."
The university also confirmed the Unibus charges were implemented following "consultation with students and will help towards environmental sustainability goals".
It added: "Disabled students may be entitled to support with travel via certain government benefits and can contact our Disability Advisers who can provide advice and guidance on how to access this."
Follow BBC Derby on Facebook, on X, or on Instagram. Send your story ideas to eastmidsnews@bbc.co.uk or via WhatsApp on 0808 100 2210.
Job cuts fears as university plans college mergers
University of Nottingham plans to cut 250 jobs
'Healthy living too expensive for teens' - study
University of Derby
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Dyslexia Canada Announces Winners of the 2025 Educational Excellence Awards
TORONTO, CANADA, June 12, 2025 / / -- Each year, Dyslexia Canada's Educational Excellence Awards recognize exceptional educators who are making a meaningful difference in the lives of students with dyslexia. These prestigious awards celebrate educators who are dedicated to embracing evidence-based practices, prioritizing early identification, and ensuring every student has the opportunity to learn to read and succeed. We are delighted to announce the winners of the 2025 Educational Excellence Awards: - Megan Norris, Literacy Coach, First Nation School Board - Whitehorse, Yukon - Pamela Guilbault, Superintendent, Catholic Independent Schools of the Nelson Diocese - Kelowna, British Columbia - Heather Kierstead, Principal, Florence MacDougall Community School, Fort Vermilion School Division - High Level, Alberta - Carrie Wood, Learning Support Teacher, Winnipeg School Division - Winnipeg, Manitoba - Sheila Piggott, Lindsay Bowen and the Literacy Team, Peterborough Victoria Northumberland Clarington Catholic District School Board - Peterborough, Ontario - Kingsdale Academy Literacy Team, led by Kathryn Byrne & Lia Ciarallo, Lester B. Pearson School Board - Montreal, Quebec - K-5 Literacy Team, Anglophone West School District - Fredericton, New Brunswick - Kimberly Phillips, School-Based Reading Specialist, Cowan Heights Elementary - St. John's, Newfoundland These educators and teams have shown exceptional leadership, creativity, and heart in transforming their classrooms, schools, districts and communities. Their efforts have not only improved literacy outcomes for students with dyslexia but have also uplifted countless others who might have otherwise struggled to learn. By setting high expectations and ensuring that all students receive the support they need to meet and exceed them, these leaders are building a culture of possibility and belonging. Dyslexia Canada proudly celebrates their impact and thanks the outstanding educators who are reshaping education through their unwavering belief in every student's potential. For more information, visit Dyslexia Canada's website. Alicia Smith Dyslexia Canada +1 705-427-9544 [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Medscape
2 hours ago
- Medscape
RCGP Urges Support to Save Declining GP Partnership Model
The Royal College of General Practitioners (RCGP) has warned that GP partnerships are under threat, as the number of partners in England has dropped by 25% over the past decade. In a new report, the college urged action to 'break down barriers to partnership' and called for modernisation of the model to make it more attractive to younger doctors. While the RCGP reaffirmed its support for the independent contractor model, it said there was 'room for modernisation and innovation', and backed ' a mixed economy' of contractual models to deliver general practice. Shift in Workforce Between 2015 and 2025, the number of GP partners in England fell from 24,491 to 18,367. Over the same period, the number of salaried GPs rose by 81%, from 10,270 in September 2015 to 18,557 in December 2024. As of June 2024, GP partners were a minority among fully qualified GPs for the first time. The most significant drop in partnership was seen in younger doctors. Among GPs aged 30-34, numbers fell by 72.9%. The only age group to show growth was those aged 60-64, up by 19.5%. Barriers to Partnership Rising workload, administrative burdens, and concerns about financial risk were cited as major deterrents to partnership. Professor Kamila Hawthorne, RCGP chair, said that many GPs were discouraged by the unlimited personal liability that comes with being a partner. She also pointed to the responsibilities of owning or leasing premises and managing staff, especially as patient demand increases. Exploring Alternatives The RCGP report explored alternative business models that could support general practice, including limited companies, limited liability partnerships (LLPs), and community benefit societies. The college maintained that partnerships still offered flexibility and potential for innovation, particularly if financial and workload pressures could be reduced. In 2024, more than half (55%) of RCGP members said they would be more likely to consider partnership if financial risks were lower. A review by Lord Darzi highlighted the financial discipline of GP partnerships, noting that they could not run large deficits like other parts of the NHS. Earlier this year, the Nuffield Trust described the current GP partnership model as 'withering'. The health think tank warned that the government's plans to improve GP access were at risk due to the fall in partner numbers. Thea Stein, chief executive of the Nuffield Trust, told Medscape News UK : 'It is hard to see partnership being the dominant model in the future.' She called for support where the model works well, but said new models must also be explored. Hawthorne maintained that 'there are elements of the traditional GP partnership that can be improved and modernised, while retaining its core strengths'. The GP partnership model has huge benefits for the NHS and for patients, she added. Government Response A Department of Health and Social Care (DHSC) spokesperson acknowledged the strengths of the partnership model, including efficiency, innovation, and continuity of care. 'However, we also recognise that this is not the only model delivering general practice,' the spokesperson told Medscape News UK . 'GP practices can choose to organise themselves in different ways and also provide good outcomes in terms of staff engagement and patient experience.'
Associated Press
2 hours ago
- Associated Press
Hematologists Set the Stage for Market Disruption as Next-Gen Hemophilia Therapies Gain Traction
EXTON, PA, June 12, 2025 (GLOBE NEWSWIRE) -- As the hemophilia landscape continues to transform, new research from Spherix Global Insights reveals a market on the cusp of significant evolution driven by innovation, physician receptivity, and an increasingly nuanced approach to patient care. The latest Market Dynamix™: Hemophilia (EU) 2025 report, based on feedback from 160 hematologists across the UK, France, Germany, Italy, and Spain, illuminates shifting treatment preferences and the widening role for advanced therapeutic options across hemophilia A and B. The study captures a broadening treatment mindset in a market historically dominated by factor replacement therapies. Although conventional agents have provided stability for many patients, Spherix data highlight an increasingly urgent unmet need, particularly among patients with inhibitors. In fact, patients with inhibitors represent the group for whom hematologists see the greatest opportunity for innovation. Products such as Alhemo (Novo Nordisk) and Qfitlia (Sanofi) are already entering the physician consciousness as promising options, with early prescribing experiences for Alhemo in Germany showing favorable clinical feedback. Importantly, European hematologists are signaling readiness to embrace novel mechanisms that deliver sustained efficacy and reduce treatment burden. Beyond Alhemo and Hympavzi, there is rising anticipation for agents like Qfitlia and Mim8 (Novo Nordisk). Gene therapy, once seen as aspirational, is becoming a more realistic consideration, especially in hemophilia B where therapeutic alternatives remain limited. CSL Behring's Hemgenix and BioMarin's Roctavian are drawing interest, albeit tempered by concerns around cost and long-term outcomes. Spherix data reveal a market increasingly driven not just by efficacy but by lifestyle alignment and convenience. This reflects a maturation of brand expectations, where baseline efficacy is presumed and differentiation hinges on quality-of-life enhancements. The move away from standard half-life (SHL) and even extended half-life (EHL) products is evident, particularly in hemophilia A, where agents like Hemlibra (Roche/Genentech) and Altuvoct/Altuviiio (Sanofi) are rapidly becoming standard practice. Underlying these trends is a broader shift in therapeutic philosophy: goals focus less and less on symptom control (which is assumed) while disease modification becomes centrally important, mirroring changes seen in other chronic specialty markets. Hematologists are prepared to make transitions, especially when options can seamlessly accommodate inhibitor development without requiring treatment change. For Hympavzi, Alhemo, and Qfitlia, upcoming Launch DynamixTM tracking among US hematologists (available June 13th) underlines similar themes, with projected prescribing steadily rising for these novel agents. Additional metrics included in launch tracking include impact of product features and manufacturer programs on prescribing, assessment of likely patient groups for initial product trialing, and perspectives on which brand(s) are likely displaced by newer market entrants. Ultimately, as the treatment paradigm continues to evolve, biopharma stakeholders seeking success in the hemophilia space will need to align not only with clinical outcomes but also with patient-centric attributes now prioritized in physician decision-making. Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents. Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand. About Spherix Global Insights Spherix is a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, across the brand lifecycle. The seasoned team of Spherix experts provides an unbiased and holistic view of the landscape within rapidly evolving specialty markets, including dermatology, gastroenterology, rheumatology, nephrology, neurology, ophthalmology, and hematology. Spherix clients stay ahead of the curve with the perspective of the extensive Spherix Physician Community. As a trusted advisor and industry thought leader, Spherix's unparalleled market insights and advisory services empower clients to make better decisions and unlock opportunities for growth. To learn more about Spherix Global Insights, visit or connect through LinkedIn. For more details on Spherix's primary market research reports and interactive dashboard offerings, visit or register here: NOTICE: All company, brand or product names in this press release are trademarks of their respective holders. The findings and opinions expressed within are based on Spherix Global Insight's analysis and do not imply a relationship with or endorsement of the companies or brands mentioned in this press release. Sarah Hendry, Hematology Franchise Head Spherix Global Insights 4848794284 [email protected]
